Risk of vertebral fractures may be increased with discontinuation of denosumab therapy.
All articles by Florence Chaverneff, PhD, Editor
-
Latest News Your top articles for Saturday
For More Personalized News -
Haymarket Medical NetworkTop Picks
- Loading...
Continuing Medical Education (CME/CE) Courses